Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.19
-0.23 (-2.21%)
At close: Oct 31, 2025, 4:00 PM EDT
10.39
+0.20 (1.96%)
After-hours: Oct 31, 2025, 5:47 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.24 billion as of October 31, 2025. Its market cap has increased by 11.65% in one year.
Market Cap
1.24B
Enterprise Value
697.21M
1-Year Change
11.65%
Ranking
Category
Stock Price
$10.19
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.24B, an increase of 618.08%. That is a compound annual growth rate of 33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 1.26B | 48.11% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |